MARKET

IRWD

IRWD

Ironwood
NASDAQ
4.680
+0.290
+6.61%
Pre Market: 4.660 -0.02 -0.43% 04:56 11/10 EST
OPEN
4.500
PREV CLOSE
4.390
HIGH
4.760
LOW
4.345
VOLUME
51
TURNOVER
0
52 WEEK HIGH
5.78
52 WEEK LOW
2.310
MARKET CAP
774.78M
P/E (TTM)
5.27
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IRWD last week (1102-1106)?
Weekly Report · 1d ago
Ironwood Pharmaceuticals, Inc. Just Beat EPS By 11%: Here's What Analysts Think Will Happen Next
Simply Wall St · 1d ago
Selling US$1.3m Of Ironwood Pharmaceuticals Stock Rewarded Insiders
Simply Wall St · 2d ago
Ironwood (IRWD) Q3 2026 Earnings Call Transcript
NASDAQ · 4d ago
What Ironwood Pharmaceuticals (IRWD) Said on Its Q3 Earnings Call
NASDAQ · 4d ago
Ironwood Q3 Net Income Rises 49%; Raises FY26 Revenue And EBITDA Outlook; Stock Up
NASDAQ · 4d ago
Ironwood Pharmaceuticals Q3 2026 Earnings Call Transcript
Benzinga · 4d ago
Ironwood reports Q3 EPS 36c, consensus 32c
TipRanks · 4d ago
More
About IRWD
Ironwood Pharmaceuticals, Inc. is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI), and rare diseases. It is focused on the development and commercialization of GI product opportunities in areas of significant unmet need. LINZESS (linaclotide), its commercial product, is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C), or chronic idiopathic constipation (CIC), and for pediatric patients ages 6-17 years-old suffering from functional constipation (FC). Linaclotide is available under the trademarked name CONSTELLA to adult men and women suffering from IBS-C or CIC and pediatric patients. The Company is also engaged in advancing apraglutide, a synthetic long-acting peptide analog of glucagon-like peptide-2 (GLP-2), for short bowel syndrome (SBS), patients who are dependent on parenteral support.

Webull offers Ironwood Pharmaceuticals, Inc. stock information, including NASDAQ: IRWD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRWD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IRWD stock methods without spending real money on the virtual paper trading platform.